MET and breast cancer: Our analysis of drug‐resistant breast cancer cells indicated that MET increased SCRIB expression, which then recruited MST1/2 and LATS1 to the plasma membrane, leading to YAP phosphorylation and its retention within the cytoplasm, and finally to inhibition of cell proliferation and invasion (Figure 7B).